Fever, dyspnea, and dry cough 7 days ago. Diagnosed with COVID-19 with positive nasal swab and IgM antibodies. Worsening dyspnea over the past 2 days. D-dimer 9.05. What are your suggestions on this?

(Edited)

6 Likes

LikeAnswersShare

previously any unilateral lung changes could think of P TB. Now Bilateral lung changes should look for COVID. We are submitting and paper on COVID and heart disease that there is connection between COVID and heart disease by reducing ACE2 receptors resulting in neutrophil rise and pulmonary edema , ARDS hypoxia and CVD we termed it as Myocardial oxygen mismatch

Treat with drugs Hydroxychloroquine 5 days azithro500 od 10 days ranivir 10 days check so 2 give oxygen 90minutes bd bilateral pneumonia

GROUND GLASS APPEARANCE . PERIPHERAL CONSOLIDATION

BLOOD = HB TLC DLC SERUM IRON ( LYMPHOCYTE COUNT ) COAGULATION PROFILE BLOOD ABG TROP I ECG RX NIV AZITHROMYCIN PCCKED CELL TRANSFUSION SOS PLASMA THERAPY ( DELHI MODEL ) PLASMA FROM COVID RECOVERED PATIENT HCQS = RESREVATION ( RECENT PAST AMERICAN STUDY ) FAVIPORAVIR& TOCILIZUMAB

Pneumonitis

Ground glass patchy PNEUMONITIS treat as per GUIDELINE

B/ L Pneumonitis COVID 19 Positive. Protocols sets by GOI or WHO must be followed under institution admission. Azithro,antiviral and ventilation can be used. Reassurance required.

Thanks Dr Pushkar Bhomia
0

View 6 other replies

CT thorax showing classical changes of organising pneumonia bilaterally. Etiology is confirmed as covid 19 swab positive. NIV sos Invasive ventilation. Plan to achieve hemodynamic stability. HCQS, azithromycin as per QTc. tocilizumab, Sarilumab are the available options in such conditions. Faviporavir has also used in some centers.

Bilateral massive diffuse pneumonitis

B/L Pneumonitis

Load more answers

Diseases Related to Discussion

Cases that would interest you